ALYSSA M RANDOLPH
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner INDIANAPOLIS, IN NPI 1922546464
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner IN Medtronic, Inc. All categories
General Payments — all program years on this page
$308.02
- Category: General Payments
- Program years: PY2024
- Record count: 7
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $308.02 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $275.75 | 6 |
| Education | $32.27 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $186.58 | 1 |
| Novo Nordisk AS | $48.54 | 2 |
| Acerta Pharma LLC | $20.57 | 1 |
| SCPHARMACEUTICALS INC. | $20.00 | 1 |
| Ardelyx, Inc. | $18.98 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.35 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $308.02 | 7 |
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100385061 | Novo Nordisk Inc | $32.27 | 10/03/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1100632393 | Novo Nordisk Inc | $16.27 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105875393 | AstraZeneca Pharmaceuticals LP | $20.57 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117010771 | Medtronic, Inc. | $186.58 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118237662 | Boehringer Ingelheim Pharmaceuticals, Inc. | $13.35 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132263440 | SCPHARMACEUTICALS INC. | $20.00 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146742104 | Ardelyx, Inc. | $18.98 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.